OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery

Injury

Volumn 39, Issue SUPPL.2, 2008, Pages

  Donati, D ^a   Bella, C Di ^a   Lucarelli, E ^a   Dozza, B ^a   Frisoni, T ^a   Aldini, N Nicoli ^a   Giardino, R ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Allograft incorporation; BMP 7; Bone regeneration; OP 1; Sheep model

Indexed keywords

RECOMBINANT OSTEOGENIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ALLOGRAFT; BONE DEFECT; BONE RADIOGRAPHY; BONE REMODELING; CONTROLLED STUDY; DRUG EFFECT; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOTOMY; PRIORITY JOURNAL; SHEEP;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BONE REMODELING; BONE TRANSPLANTATION; BONY CALLUS; DISEASE MODELS, ANIMAL; METATARSAL BONES; OSTEOTOMY; RECOMBINANT PROTEINS; SHEEP;

EID: 51649108090     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1383(08)70017-2     Document Type: Article

References (48)

1. Donati D., Di Liddo M., Zavatta M., et al. Massive bone allograft reconstruction in high-grade osteosarcoma. Clin Orthop Relat Res 377 (2000) 186-194
2. Hazan E.J., Hornicek F.J., Tomford W., et al. The effect of adjuvant chemotherapy on osteoarticular allografts. Clin Orthop Relat Res 385 (2001) 176-181
3. Mankin H.J., Gebhardt M.C., Jennings L.C., et al. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res 324 (1996) 86-97
4. Caldora P., Donati D., Capanna R., et al. Studio istomorfologico degli espianti di innesti omoplastici massivi: Risultati preliminari. Chir Org Mov 80 (1995) 191-205
5. Enneking W.F., and Campanacci D.A. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am 83-A 7 (2001) 971-986
6. Enneking W.F., and Mindell E.R. Observations on massive retrieved human allografts. J Bone Joint Surg Am 73 8 (1991) 1123-1142
7. Berrey Jr. B.H., Lord C.F., Gebhardt M.C., et al. Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am 72 6 (1990) 825-833
8. Hornicek F.J., Gebhardt M.C., Tomford W.W., et al. Factors affecting non-union of the allograft-host junction. Clin Orthop Relat Res 382 (2001) 87-98
9. Kanczler J.M., and Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15 (2008) 100-114
10. Reddi A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 6 4 (2000) 351-359
11. Urist M.R. Bone: formation by autoinduction. Science 150 698 (1965) 893-899
12. Giannoudis P.V., Dinopoulos H., and Tsiridis E. Bone substitutes: an update. Injury 36 Suppl 3 (2005) S20-S27
13. Anand N., Hamilton J.F., Perri B., et al. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome. Spine 31 20 (2006) E748-E753
14. Salkeld S.L., Patron L.P., Barrack R.L., et al. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 83-A 6 (2001) 803-816
15. Cook S.D., and Rueger D.C. Osteogenic protein-1: biology and applications. Clin Orthop Relat Res 324 (1996) 29-38
16. Ripamonti U., Ramoshebi L.N., Matsaba T., et al. Bone induction by BMPs/OPs and related family members in primates. J Bone Joint Surg Am 83A Suppl 1 (2001) S116-S127 (Pt 2))
17. Schmitt J.M., Hwang K., Winn S.R., et al. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 17 2 (1999) 269-278
18. Bostrom M., Lane J.M., Tomin E., et al. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop Relat Res 327 (1996) 272-282
19. Bostrom M.P., and Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 355 Suppl (1998) S274-S282
20. Calori G.M., D'Avino M., Tagliabue L., et al. An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 37 Suppl 3 (2006) S43-S50
21. Cook S.D., Baffes G.C., Wolfe M.W., et al. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 301 (1994) 302-312
22. Giannoudis P.V., Psarakis S., Kanakaris N.K., et al. Biological enhancement of bone healing with Bone Morphogenetic Protein-7 at the clinical setting of pelvic girdle non-unions. Injury 38 Suppl 4 (2007) S43-S48
23. Giannoudis P.V., and Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury 36 Suppl 3 (2005) S47-S50
24. Kanakaris N.K., Paliobeis C., Nlanidakis N., et al. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury 38 Suppl 2 (2007) S65-S75
25. Mahendra A., and Maclean A.D. Available biological treatments for complex non-unions. Injury 38 Suppl 4 (2007) S7-12
26. Ronga M., Baldo F., Zappala G., et al. Recombinant human bone morphogenetic protein-7 for treatment of long bone non-union: an observational, retrospective, non-randomized study of 105 patients. Injury 37 Suppl 3 (2006) S51-S56
27. Schimandle J.H., Boden S.D., and Hutton W.C. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20 12 (1995) 1326-1337
28. Schmidmaier G., Schwabe P., Wildemann B., et al. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38 Suppl 4 (2007) S35-S41
29. Vaibhav B., Nilesh P., Vikram S., et al. Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 38 11 (2007) 1227-1235
30. Cook S.D., Wolfe M.W., Salkeld S.L., et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 77 5 (1995) 734-750
31. Lietman S.A., Inoue N., Rafiee B., et al. The effect of recombinant human osteogenic protein-1 on allograft incorporation. J Bone Joint Surg Br 87 9 (2005) 1292-1297
32. Giannoudis P.V., Kanakaris N.K., and Einhorn T.A. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int 18 12 (2007) 1565-1581
33. Gordh M., Alberius P., Johnell O., et al. Effects of rhBMP-2 and osteopromotive membranes on experimental bone grafting. Plast Reconstr Surg 103 7 (1999) 1909-1918
34. Itoh K., Udagawa N., Katagiri T., et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142 8 (2001) 3656-3662
35. Kanatani M., Sugimoto T., Kaji H., et al. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10 11 (1995) 1681-1690
36. Koide M., Murase Y., Yamato K., et al. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 259 1 (1999) 97-102
37. Cullinane D.M., Lietman S.A., Inoue N., et al. The effect of recombinant human osteogenic protein-1 (bone morphogenetic protein-7) impregnation on allografts in a canine intercalary bone defect. J Orthop Res 20 6 (2002) 1240-1245
38. Kaigler D., Krebsbach P.H., Polverini P.J., et al. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9 1 (2003) 95-103
39. Marx R.E., Carlson E.R., Eichstaedt R.M., et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 6 (1998) 638-646
40. Lucarelli E., Fini M., Beccheroni A., et al. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res 435 (2005) 62-68
41. Gerhart T., Kirker-Head C., Kriz M.L., et al. Healing segmental defects in sheep using recombinant human bone morphogenetic protein (BMP-2). Trans Orthop Res Soc (1991) 16172
42. Duneas N., Crooks J., and Ripamonti U. Transforming growth factor-beta 1: induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7). Growth Factors 15 4 (1998) 259-277
43. Matsaba T., Ramoshebi L.N., Crooks J., et al. Transforming growth factor-beta1 supports the rapid morphogenesis of heterotopic endochondral bone initiated by human osteogenic protein-1 via the synergistic upregulation of molecular markers. Growth Factors 19 2 (2001) 73-86
44. Tsiridis E., Upadhyay N., and Giannoudis P. Molecular aspects of fracture healing: which are the important molecules?. Injury 38 Suppl 1 (2007) S11-S25
45. Corsi K.A., Schwarz E.M., Mooney D.J., et al. Regenerative medicine in orthopaedic surgery. J Orthop Res 25 10 (2007) 1261-1268
46. Tagil M., Jeppsson C., and Aspenberg P. Bone graft incorporation. Effects of osteogenic protein-1 and impaction. Clin Orthop Relat Res 371 (2000) 240-245
47. Martini L., Fini M., Giavaresi G., et al. Sheep model in orthopedic research: a literature review. Comp Med 51 4 (2001) 292-299
48. Urist M.R. Bone transplants and implants. Fundamental and Clinical Bone Physiology (1980), Lippincott, Philadelphia 331-368